Scilex defers $6.25M amortization payment, issues 5M shares to noteholders

Scilex Holding Co

Entered deferral letters with Tranche B noteholders; first $6.25M amortization due Jan 2 deferred to Jan 31, then to Oct 8, 2026.
Delivered 5M common shares to noteholders: Oramed 2.5M, BPY 720k, Nomis 1.28M, 3i LP 500k.
Paid $1.11M toward amortization and make-whole interest to achieve further deferral to Oct 8, 2026.
Term sheet provides for 4% royalty on worldwide net sales of Gloperba and Elyxyb (ex-Canada) for 10 years.
Company seeking to extend Oramed promissory note maturity from March 21, 2025 to Dec 31, 2025; not yet agreed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.